ERBB2 and breast cancer: When we then subdivided patients based on their breast cancer type (Basal, Luminal A, Luminal B, HER2+), we found that patients with Basal, Luminal A, or Luminal B cancers who exhibiting high LINC00899 expression lived longer (Figure 2C).